logo-loader
viewAmazon.com, Inc.

Amazon enters healthcare sector with online pharmacy launch

The online service will deliver medication and prescription refills to customers

Amazon.com, Inc. - Amazon enters healthcare sector with online pharmacy launch

Amazon Inc (NASDAQ:AMZN) has entered a new sector after opening an online pharmacy on Tuesday.

The online behemoth is providing a service to deliver medication and prescription refills to customers, who can order through a secure pharmacy profile, in a couple of days.

READ: Amazon slides as EU unveils antitrust charges

The service will begin in the US with prescribed medications, even those that require refrigeration such as insulin, and will not offer formulations that can be abused such as those that contain opioids.

The website will use Pillpack’s infrastructure, which was acquired for US$753mln in 2018, though PillPack remains a distinct service for customers managing multiple daily medications for chronic conditions.

Prime members will be able to access savings on medications at Amazon Pharmacy when paying without insurance, as well as at over 50,000 other participating pharmacies nationwide.

The news prompted pharmacy chains Walgreens Boots Alliance Inc (NASDAQ:WBA) and CVS Health Corp (NYSE:CVS) to drop 8% to US$40.55 and 3.7% to US$68.38 respectively at open. Meanwhile, Amazon rose 1% to US$3,151.99.

These companies rely on extra purchases such as shampoo or groceries to plump revenues alongside the medicines.

They have all boosted their online capabilities but they are competing with the well-oiled Amazon machine which may be about to disrupt yet another sector.

Quick facts: Amazon.com, Inc.

Price: 3195.34 USD

NASDAQ:AMZN
Market: NASDAQ
Market Cap: $1.6 trillion
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

IXICO signs contract to provide neuroimaging services for clinical trial for...

IXICO PlC (AIM: IXI) Chief Commercial Officer, Lammert Albers joined Steve Darling from Proactive with news the company is to provide neuroimaging services that will support a phase Ib/II clinical trial for Huntington’s disease. Albers telling Proactive "these services will enable clients to...

15 hours, 22 minutes ago

2 min read